Lebellec, L., Bertucci, F., Tresch-Bruneel, E., Bompas, E., Toiron, Y., Camoin, L., . . . Penel, N. (2016). Circulating vascular endothelial growth factor (VEGF) as predictive factor of progression-free survival in patients with advanced chordoma receiving sorafenib: An analysis from a phase II trial of the french sarcoma group (GSF/GETO). Oncotarget.
শিকাগো স্টাইলে সাইটেশনLebellec, Loic, et al. "Circulating Vascular Endothelial Growth Factor (VEGF) As Predictive Factor of Progression-free Survival in Patients With Advanced Chordoma Receiving Sorafenib: An Analysis From a Phase II Trial of the French Sarcoma Group (GSF/GETO)." Oncotarget 2016.
এমএলএ সাইটেশনLebellec, Loic, et al. "Circulating Vascular Endothelial Growth Factor (VEGF) As Predictive Factor of Progression-free Survival in Patients With Advanced Chordoma Receiving Sorafenib: An Analysis From a Phase II Trial of the French Sarcoma Group (GSF/GETO)." Oncotarget 2016.